Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Picower Institute presents new immunotherapeutic anticancer agents

March 17, 2000

Antisoma takes up another product from ICRF for clinical development

March 17, 2000

Low-dose M-Vax shows promise in stage III metastatic melanoma

March 17, 2000

Seattle Genetics updates MAb program

March 17, 2000

IND filed by NeoPharm for glioblastoma treatment

March 16, 2000

OvaRex shows evidence of cellular immune response

March 14, 2000

The FDA approves Pacis immunotherapy for treatment of bladder cancer

March 13, 2000

SciClone's Zadaxin boosts immune recognition of tumor cells

March 8, 2000

Antigenic telomerase-derived proteins/peptides for cancer

March 6, 2000

Antitumor immunity induced by elemene involves enhancement of HSP70 expression

March 2, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...